EWING, N.J.--(BUSINESS WIRE)--Antares Pharma (AMEX:AIS), announced that it has entered into definitive purchase agreements for a $15 million gross private placement of newly issued shares of common stock and the concurrent issuance of warrants for the purchase of additional shares of common stock to institutional and other accredited investors. The financing is expected to close after receipt of AMEX approval.
